https://www.selleckchem.com/products/ml324.html
The pooled 1-year local control rate was 80% (95% confidence interval [CI], 76%-83%). The pooled 1-year overall survival rate was 77% (95% CI, 70%-83%). The overall rate of severe adverse events after ablation (CTCAE grade 3 or higher) was 16.1%. The overall rate of low-grade adverse events after ablation (CTCAE grade 2 or lower) was 32.6%. Approximately 21.9% (n= 203) of patients experienced intraprocedural hypertensive crises, the majority of which were reversed with antihypertensive medications. This study demonstrates that image-guide
Like
Comment
Share
